|
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
|
17 September 2010 |
|
GSK and BJD collaborate on a new educational programme to reduce global burden of joint pain
|
14 September 2010 |
|
BBC Panorama: "A Risk Worth Taking?" Programme. GlaxoSmithKline Right of Reply Statement
|
07 September 2010 |
|
Reports of narcolepsy in Europe following vaccination with Pandemrix™
|
06 September 2010 |
|
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles
|
24 August 2010 |
|
GlaxoSmithKline and Human Genome Sciences announce FDA priority review designation for Benlysta®
|
20 August 2010 |
|
Image of new antibiotic in action opens up new opportunities
|
09 August 2010 |
|
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
|
22 July 2010 |
|
GlaxoSmithKline (GSK) responds to Senate Finance Committee letter
|
14 July 2010 |
|
Data support Avandia (rosiglitazone maleate) cardiovascular safety profile
|
12 July 2010 |